BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26361682)

  • 1. Ischemia/reperfusion-induced Kidney Injury in Heterozygous PACAP-deficient Mice.
    Laszlo E; Varga A; Kovacs K; Jancso G; Kiss P; Tamas A; Szakaly P; Fulop B; Reglodi D
    Transplant Proc; 2015 Sep; 47(7):2210-5. PubMed ID: 26361682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) show increased susceptibility to in vivo renal ischemia/reperfusion injury.
    Szakaly P; Laszlo E; Kovacs K; Racz B; Horvath G; Ferencz A; Lubics A; Kiss P; Tamas A; Brubel R; Opper B; Baba A; Hashimoto H; Farkas J; Matkovits A; Magyarlaki T; Helyes Z; Reglodi D
    Neuropeptides; 2011 Apr; 45(2):113-21. PubMed ID: 21211837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Effect of PACAP on Ischemia/Reperfusion-Induced Kidney Injury of Male and Female Rats: Gender Differences.
    Laszlo E; Juhasz T; Varga A; Czibere B; Kovacs K; Degrell P; Horvath G; Jancso G; Szakaly P; Tamas A; Reglodi D
    J Mol Neurosci; 2019 Jul; 68(3):408-419. PubMed ID: 30443839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of PACAP on mitochondrial apoptotic pathways and cytokine expression in rats subjected to renal ischemia/reperfusion.
    Horvath G; Racz B; Reglodi D; Kovacs K; Kiss P; Gallyas F; Bognar Z; Szabo A; Magyarlaki T; Laszlo E; Lubics A; Tamas A; Toth G; Szakaly P
    J Mol Neurosci; 2010 Nov; 42(3):411-8. PubMed ID: 20229361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice deficient in pituitary adenylate cyclase activating polypeptide display increased sensitivity to renal oxidative stress in vitro.
    Horvath G; Mark L; Brubel R; Szakaly P; Racz B; Kiss P; Tamas A; Helyes Z; Lubics A; Hashimoto H; Baba A; Shintani N; Furjes G; Nemeth J; Reglodi D
    Neurosci Lett; 2010 Jan; 469(1):70-4. PubMed ID: 19932736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of pituitary adenylate cyclase activating polypeptide in renal ischemia/reperfusion.
    László E; Kiss P; Horváth G; Szakály P; Tamás A; Reglődi D
    Acta Biol Hung; 2014 Dec; 65(4):369-78. PubMed ID: 25475976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) is Protective in Inflammation and Oxidative Stress-Induced Damage in the Kidney.
    Horvath G; Opper B; Reglodi D
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31591326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PACAP is an endogenous protective factor-insights from PACAP-deficient mice.
    Reglodi D; Kiss P; Szabadfi K; Atlasz T; Gabriel R; Horvath G; Szakaly P; Sandor B; Lubics A; Laszlo E; Farkas J; Matkovits A; Brubel R; Hashimoto H; Ferencz A; Vincze A; Helyes Z; Welke L; Lakatos A; Tamas A
    J Mol Neurosci; 2012 Nov; 48(3):482-92. PubMed ID: 22528455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of endogenous antioxidant systems in the protective activity of pituitary adenylate cyclase-activating polypeptide against hydrogen peroxide-induced oxidative damages in cultured rat astrocytes.
    Douiri S; Bahdoudi S; Hamdi Y; Cubì R; Basille M; Fournier A; Vaudry H; Tonon MC; Amri M; Vaudry D; Masmoudi-Kouki O
    J Neurochem; 2016 Jun; 137(6):913-30. PubMed ID: 26991551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The enhancement of endogenous cAMP with pituitary adenylate cyclase-activating polypeptide protects rat kidney against ischemia through the modulation of inflammatory response.
    Riera M; Torras J; Cruzado JM; Lloberas N; Liron J; Herrero I; Navarro MA; Grinyo JM
    Transplantation; 2001 Oct; 72(7):1217-23. PubMed ID: 11602845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in pituitary adenylate cyclase-activating polypeptide following renal ischemia-reperfusion in rats.
    Szakaly P; Horvath G; Kiss P; Laszlo E; Farkas J; Furjes G; Nemeth J; Reglodi D
    Transplant Proc; 2010; 42(6):2283-6. PubMed ID: 20692463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice deficient in neuropeptide PACAP demonstrate increased sensitivity to in vitro kidney hypoxia.
    Horvath G; Racz B; Szakaly P; Kiss P; Laszlo E; Hau L; Tamas A; Helyes Z; Lubics A; Hashimoto H; Baba A; Reglodi D
    Transplant Proc; 2010; 42(6):2293-5. PubMed ID: 20692466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells.
    Horvath G; Brubel R; Kovacs K; Reglodi D; Opper B; Ferencz A; Szakaly P; Laszlo E; Hau L; Kiss P; Tamas A; Racz B
    J Mol Neurosci; 2011 Jan; 43(1):67-75. PubMed ID: 20676802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pituitary adenylate cyclase activating polypeptide in the urinary system, with special emphasis on its protective effects in the kidney.
    Reglodi D; Kiss P; Horvath G; Lubics A; Laszlo E; Tamas A; Racz B; Szakaly P
    Neuropeptides; 2012 Apr; 46(2):61-70. PubMed ID: 21621841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of calcium-binding protein expression in the inner ear of wild-type, heterozygous and homozygous pituitary adenylate cyclase-activating polypeptide (PACAP)-knockout mice in kanamycin-induced ototoxicity.
    Nemeth A; Szabadfi K; Fulop B; Reglodi D; Kiss P; Farkas J; Szalontai B; Gabriel R; Hashimoto H; Tamas A
    Neurotox Res; 2014 Jan; 25(1):57-67. PubMed ID: 24155155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mesenchymal stem/stromal cells suppress spinal inflammation in mice with contribution of pituitary adenylate cyclase-activating polypeptide (PACAP).
    Tsumuraya T; Ohtaki H; Song D; Sato A; Watanabe J; Hiraizumi Y; Nakamachi T; Xu Z; Dohi K; Hashimoto H; Atsumi T; Shioda S
    J Neuroinflammation; 2015 Feb; 12():35. PubMed ID: 25889720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide PACAP in mouse liver ischemia and reperfusion injury: immunomodulation by the cAMP-PKA pathway.
    Ji H; Zhang Y; Shen XD; Gao F; Huang CY; Abad C; Busuttil RW; Waschek JA; Kupiec-Weglinski JW
    Hepatology; 2013 Mar; 57(3):1225-37. PubMed ID: 22532103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary Adenylate Cyclase-activating Polypeptides Prevent Hepatocyte Damage by Promoting Yes-associated Protein in Liver Ischemia-Reperfusion Injury.
    Liu Y; Lu T; Zhang C; Xue Z; Xu J; Busuttil RW; Xia Q; Xu N; Kupiec-Weglinski JW; Ji H
    Transplantation; 2019 Aug; 103(8):1639-1648. PubMed ID: 31348437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Oxidative Stress in Zebrafish Hair Cells.
    Kasica N; Podlasz P; Sundvik M; Tamas A; Reglodi D; Kaleczyc J
    Neurotox Res; 2016 Nov; 30(4):633-647. PubMed ID: 27557978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes and effect of PACAP-38 on intestinal ischemia-reperfusion and autotransplantation.
    Ferencz A; Rácz B; Tamás A; Nedvig K; Németh J; Kalmár-Nagy K; Horváth OP; Wéber G; Röth E; Reglödi D
    Transplant Proc; 2009; 41(1):57-9. PubMed ID: 19249475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.